Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 791 across all filing types
Latest filing 2023-07-05 Regulatory Filings
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2023. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialized/rematerialized securities details submitted to stock exchanges. The document is short (3164 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion. It is not an announcement of voting results, board changes, or capital changes. It fits best under Regulatory Filings (RNS) as a compliance certificate under SEBI regulations.
2023-07-05 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (NSE and BSE) regarding the signing of a Memorandum of Understanding (MoU) between Shalby Academy (a unit of Shalby Ltd.) and Sardar Vallabhbhai Global University. It describes the partnership for educational programs and training but does not contain any financial data, report, or regulatory filing beyond this announcement. The document references compliance with SEBI Listing Obligations Regulation 30, which pertains to disclosure of material events. The content is an announcement of a corporate event rather than a financial report, management change, or other specific filing type. Given the nature and length (2229 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2023-07-04 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the closure of the trading window in compliance with SEBI regulations on insider trading. It specifies the period during which insiders are prohibited from trading securities due to the upcoming declaration of unaudited financial results for the quarter ended June 30, 2023. The document is an announcement about trading restrictions and does not contain any financial data, report content, or detailed financial results. It is also relatively short (1637 characters). Therefore, it is not a financial report or earnings release but a regulatory announcement related to insider trading compliance. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2023-06-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding a scheduled meeting with investors and analysts. It references compliance with SEBI Listing Obligations and Disclosure Requirements (Regulation 30), which pertains to disclosure of material events. The content explicitly states that no unpublished price sensitive information will be shared and is essentially an announcement of an investor meeting. There are no financial statements, detailed financial data, or report contents included. The document length is only 1572 characters, which is quite short and consistent with a regulatory announcement rather than a full report or transcript. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other more specific categories like Investor Presentation or Call Transcript, which would contain detailed content. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-06-29 English
Memorandum of Understanding/Agreements
Regulatory Filings Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (NSE and BSE) regarding the signing of an agreement with a hospital in Ranchi to establish a franchise-owned, Shalby-managed hospital. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about a strategic business collaboration and expansion, not a financial report, audit, or management change. The document length is short (2513 characters) and it is an announcement of a corporate event rather than a detailed report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-27 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification on the increase in trading volume of the company's security. It references compliance with SEBI regulations and states that there is no undisclosed information affecting price or volume. The document is short (1500 characters) and serves as a regulatory clarification or response rather than a financial report or announcement of results. It does not contain financial data, management changes, or voting results. It is best classified as a Regulatory Filing (RNS) since it is a compliance-related disclosure that does not fit other specific categories.
2023-06-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.